AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2025
Mar 11, 2025
33298_dirs_2025-03-10_c0431cda-2ef4-4170-8ae8-c934891675c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2025-03-06
Reporting Person: Galluppi Stefan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-06 | Common Shares | A | 60000 | — | Acquired | 105449 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 1644800 | Indirect |
Footnotes
F1: Represents grant of restricted shares which vests on January 1 2026.
F2: American Nutra Tech, LLC is wholly-owned by the reporting person.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Capital/Financing Update
2026
Apr 1
Regulatory Filings
2026
Mar 23
Capital/Financing Update
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Earnings Release
2025
Nov 17